← Leaderboards
Boris Y Zaslavsky
Analiza, Inc.
$1,197,104
Attributed
$1,197,104
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,197,104 · 3
By mechanism
R44$977,295 · 1
R43$219,809 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Method Development”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$370,834,572
- Richard K. Wilson · Washington University$345,937,296
- Richard A Gibbs · Baylor College Of Medicine$329,093,388
- Lawrence Corey · Fred Hutchinson Cancer Center$318,434,103
- George R Seage · Abt Associates, Inc.$292,142,010
- Eric S Lander · Whitehead Institute For Biomedical Res$262,517,055
Research focus
Method DevelopmentProtein Structure FunctionBiotherapeutic AgentPeptidesAcidity /AlkalinityBiological ProductsChemical Structure FunctionDrug Design /Synthesis /ProductionDrug Discovery /IsolationDrug Screening /EvaluationHydropathyAnalytical ChemistryDrug Quality /StandardRecombinant ProteinsStatistics /BiometryTechnology /Technique Development2,4 DinitrophenolVaccine DevelopmentBioassayBiomedical AutomationBiotechnologyBioterrorism /Chemical WarfareBotulinum ToxinsChemical Fingerprinting
Grant awards (5)
Structural Signatures for Quality Control of Proteins$120,567
R43 · FY2004 · GM
NEW METHOD FOR QSAR FOR BIOPHARMACEUTICAL PRODUCTS$207,298
R44 · FY2002 · GM
Rapid Quality Control Technology for Biodefense Vaccines$99,242
R43 · FY2002 · AI
NEW METHOD FOR QSAR FOR BIOPHARMACEUTICAL PRODUCTS$392,690
R44 · FY2001 · GM
NEW METHOD FOR QSAR FOR BIOPHARMACEUTICAL PRODUCTS$377,307
R44 · FY2000 · GM